ANTINUCLEAR ANTIBODY (ANA) - ANVISA Registration 80944340031

Access comprehensive regulatory information for ANTINUCLEAR ANTIBODY (ANA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80944340031 and manufactured by IMMCO DIAGNOSTICS, INC.. The registration is held by TRINITY BIOTECH DO BRASIL COMÉRCIO E IMPORTAÇÃO LTDA. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including INOVA DIAGNOSTICS, INC., ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80944340031
Registration Details
ANVISA Registration Number: 80944340031
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Immuglo anti-nDNA Antibody IFA Kit
Risk Class II

Registration Details

80944340031

25351052137201917

15648426000123

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Apr 15, 2019

VIGENTE

09/18/2025 19:00:01